Becton Dickinson & Co (BDX)
234.36
+0.48
(+0.21%)
USD |
NYSE |
Apr 23, 16:00
234.25
-0.11
(-0.05%)
Pre-Market: 20:00
Becton Dickinson Cash from Investing (Quarterly): -233.00M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -233.00M |
| September 30, 2023 | 137.00M |
| June 30, 2023 | -329.00M |
| March 31, 2023 | -233.00M |
| December 31, 2022 | -291.00M |
| September 30, 2022 | -2.005B |
| June 30, 2022 | -236.00M |
| March 31, 2022 | -304.00M |
| December 31, 2021 | -686.00M |
| September 30, 2021 | -694.00M |
| June 30, 2021 | -323.00M |
| March 31, 2021 | -433.00M |
| December 31, 2020 | -430.00M |
| September 30, 2020 | -327.00M |
| June 30, 2020 | -363.00M |
| March 31, 2020 | -255.00M |
| December 31, 2019 | -287.00M |
| September 30, 2019 | -441.00M |
| June 30, 2019 | -330.00M |
| March 31, 2019 | -269.00M |
| December 31, 2018 | 299.00M |
| September 30, 2018 | -560.00M |
| June 30, 2018 | 200.00M |
| March 31, 2018 | -170.00M |
| December 31, 2017 | -15.20B |
| Date | Value |
|---|---|
| September 30, 2017 | -347.00M |
| June 30, 2017 | -381.00M |
| March 31, 2017 | -203.00M |
| December 31, 2016 | 48.00M |
| September 30, 2016 | -351.00M |
| June 30, 2016 | -148.00M |
| March 31, 2016 | -25.00M |
| December 31, 2015 | -145.00M |
| September 30, 2015 | -315.00M |
| June 30, 2015 | -174.00M |
| March 31, 2015 | -8.197B |
| December 31, 2014 | 368.00M |
| September 30, 2014 | -218.00M |
| June 30, 2014 | -232.00M |
| March 31, 2014 | -231.00M |
| December 31, 2013 | -267.00M |
| September 30, 2013 | -607.00M |
| June 30, 2013 | -119.00M |
| March 31, 2013 | 25.00M |
| December 31, 2012 | 390.00M |
| September 30, 2012 | -251.83M |
| June 30, 2012 | -422.16M |
| March 31, 2012 | 26.02M |
| December 31, 2011 | -252.03M |
| September 30, 2011 | -208.92M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-2.005B
Minimum
Sep 2022
137.00M
Maximum
Sep 2023
-424.37M
Average
-327.00M
Median
Sep 2020
Cash from Investing (Quarterly) Benchmarks
| AngioDynamics Inc | 29.40M |
| West Pharmaceutical Services Inc | -108.80M |
| Integer Holdings Corp | -80.58M |
| Merit Medical Systems Inc | -8.343M |
| Insulet Corp | -31.60M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 841.00M |
| Cash from Financing (Quarterly) | -862.00M |
| Free Cash Flow | 2.648B |
| Free Cash Flow Per Share (Quarterly) | 2.488 |
| Free Cash Flow to Equity (Quarterly) | 494.00M |
| Free Cash Flow to Firm (Quarterly) | 785.48M |
| Free Cash Flow Yield | 3.90% |